Media

Bonesupport: Pipeline Project Targeting Bioceramics Capable of Enhancing Bone Growth Awarded SEK 8 million Grant from Vinnova Sweden

Orexo Interim Report Q2 2017 and business update

Nordic Nanovector ASA: Increase of share capital/mandatory notification of trade

Nordic Nanovector ASA: Mandatory notification of trade – primary insider

Onxeo Announces Positive Preclinical Proof of Concept Results Confirming AsiDNA™ Activity via Systemic Administration

Trimb acquires well-established OTC products in Europe

Strongbridge Biopharma plc Completes Target Enrollment of 90 Patients in the Phase 3 SONICS Study Evaluating RECORLEV™ (levoketoconazole) in Endogenous Cushing’s Syndrome

Nexstim Plc Files 510(k) Submission for its NBT® system for the Treatment of Depression with US FDA

Strongbridge Biopharma plc Added to the Russell 3000® Index

Final price in BONESUPPORT™’s initial public offering set at SEK 29 per share – trading on Nasdaq Stockholm commences today